SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,525,000 | -61.6% | 2,623,077 | -52.5% | 0.00% | -100.0% |
Q1 2022 | $6,576,000 | -77.7% | 5,526,376 | -39.0% | 0.00% | -50.0% |
Q4 2021 | $29,539,000 | -27.1% | 9,061,297 | +0.0% | 0.00% | -33.3% |
Q3 2021 | $40,493,000 | -17.9% | 9,058,845 | +0.1% | 0.00% | -25.0% |
Q2 2021 | $49,311,000 | -26.9% | 9,047,965 | +0.4% | 0.00% | -33.3% |
Q1 2021 | $67,433,000 | -6.4% | 9,015,112 | +35.8% | 0.01% | 0.0% |
Q4 2020 | $72,053,000 | +22.9% | 6,640,835 | +0.1% | 0.01% | 0.0% |
Q3 2020 | $58,641,000 | -16.9% | 6,633,550 | +0.2% | 0.01% | -25.0% |
Q2 2020 | $70,603,000 | +89.6% | 6,623,200 | +5.5% | 0.01% | +60.0% |
Q1 2020 | $37,234,000 | -12.2% | 6,278,984 | +2.3% | 0.01% | 0.0% |
Q4 2019 | $42,396,000 | -33.4% | 6,135,409 | +0.0% | 0.01% | -37.5% |
Q3 2019 | $63,681,000 | +12.1% | 6,134,961 | +0.0% | 0.01% | +14.3% |
Q2 2019 | $56,805,000 | +23.1% | 6,134,442 | +21.5% | 0.01% | +16.7% |
Q1 2019 | $46,140,000 | +64.1% | 5,048,158 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $28,118,000 | -53.2% | 5,048,158 | 0.0% | 0.00% | -42.9% |
Q3 2018 | $60,124,000 | +20.5% | 5,048,158 | +3.3% | 0.01% | +16.7% |
Q2 2018 | $49,894,000 | -20.4% | 4,886,748 | +1.2% | 0.01% | -14.3% |
Q1 2018 | $62,682,000 | +63.3% | 4,829,094 | +22.4% | 0.01% | +75.0% |
Q4 2017 | $38,380,000 | -33.8% | 3,944,465 | +0.1% | 0.00% | -42.9% |
Q3 2017 | $57,983,000 | -8.2% | 3,939,030 | +0.3% | 0.01% | -12.5% |
Q2 2017 | $63,185,000 | +13.0% | 3,926,998 | +11.9% | 0.01% | +14.3% |
Q1 2017 | $55,897,000 | +31.1% | 3,508,937 | +0.1% | 0.01% | +16.7% |
Q4 2016 | $42,646,000 | -12.3% | 3,507,070 | +0.0% | 0.01% | 0.0% |
Q3 2016 | $48,631,000 | +28.5% | 3,506,155 | +15.8% | 0.01% | +20.0% |
Q2 2016 | $37,841,000 | – | 3,027,285 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |